aknefug-el 10 mg/ml uz ādas lietojams šķīdums
dr. august wolff gmbh & co. kg arzneimittel, germany - eritromicīns - uz ādas lietojams šķīdums - 10 mg/ml
dalacin t 10 mg/ml šķīdums ārīgai lietošanai
pfizer europe ma eeig, belgium - klindamicīns - uz ādas lietojams šķīdums - 10 mg/ml
treclinac 10 mg/0,25 mg/g gels
viatris healthcare limited, ireland - clindamycinum, tretinoinum - gels - 10 mg/0,25 mg/g
duac gel 10 mg/g + 50 mg/g gels
glaxosmithkline trading services limited, ireland - clindamycinum, benzoylis peroxidum - gels - 10 mg/g + 50 mg/g
irexime 10 mg/g + 50 mg/g gels
orifarm healthcare a/s, denmark - clindamycinum, benzoylis peroxidum - gels - 10 mg/g + 50 mg/g
tafinlar
novartis europharm limited - dabrafenib mesilate - melanoma - antineoplastiski līdzekļi - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 un 5. palīgvielu attieksmi pret melanomadabrafenib kopā ar trametinib ir norādīts palīgvielu ārstēšanai pieaugušiem pacientiem ar iii stadijā melanomas ar braf v600 mutācijas, pēc pilnīgas rezekcija. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiski līdzekļi - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
vyndaqel
pfizer europe ma eeig - tafamidis - amiloidoze - other nervous system drugs - vyndaqel tiek norādīts transthyretin amyloidosis pieaugušiem pacientiem ar 1. posms simptomātiska polineiropātijas aizkavēt perifērijas neiroloģisku traucējumu ārstēšanai.
nitigraf 647 mg/ml šķīdums injekcijām
juste s.a.q.f., spain - joheksols - Šķīdums injekcijām - 647 mg/ml